White Paper

Groups: Harmonizing the market-based prices within a pharmacy network

94% of pharmacies belong to a group (Court of Auditors, May 2025). However, when it comes to non-reimbursable medications, over-the-counter products, and dietary supplements, each pharmacy owner is free to set their own prices, and the price of the same product can vary from one pharmacy within the same chain to another. Patients, however, see only one brand: this inconsistency damages the brand’s price image, leaves profit on the table, and muddies joint promotional efforts.

This white paper proposes a three-tiered pricing policy: a common suggested retail price for the most frequently compared products, a price range for the core product line, and complete freedom for personalized recommendations. All of this is in compliance with the law (no minimum prices imposed, independence of the retailer, and a 30-day reference price). Audited figures from 2023 to 2026 (Court of Auditors, IGF-IGAS, NèreS, and OpenHealth Company).

When you download it, you'll discover

  • Why does the price of the same product vary from one pharmacy in the network to another, and what price differences are justified?
  • The Cost of Inconsistent Pricing to the Retailer: Price Perception, Lost Profit Margin, and Confusing Promotions
  • What a consortium can recommend, and what it cannot require
  • How to classify each product based on network pricing, pricing corridor, and the incumbent's pricing flexibility
  • How to align prices 30 days before a joint promotion so that the strikethrough price is correct in every pharmacy
The Essentials

A pharmacy chain doesn't need a single price; it needs a common rule. Between mandated prices, prohibited prices, and total freedom—which can confuse customers—a suggested price on visible products gives the owner the final say.

94%of pharmacies belong to a group (2023 data)Court of Auditors, RALFSS 2025, May 2025
30%of pharmacies operate under a brand nameDGE and Xerfi, cited by the Court of Auditors, May 2025
15%of pharmacy revenue comes from non-reimbursed sales, compared to 85% from reimbursed sales (2023)Court of Auditors, RALFSS 2025, May 2025
What You'll Take Away
Almost all pharmacies belong to a chain, but when it comes to products with unregulated prices, each one remains a pricing island, with its own pricing factors and practices.
Unregulated prices account for only a small portion of total revenue, but they are the prices that patients see, pay out of pocket, and compare across different stores of the same chain.
As purchasing becomes an increasingly minor differentiator among retail groups, the value of a retail chain shifts toward product assortment, brand, and selling price.
Harmonizing prices does not mean raising them: some prices go up, others go down. Under the 30-day rule, a joint promotion begins one month before the flyer is distributed.
Author: Dorothée Fouissac, Product and Project Director, BOOPER · Figures verified at the source on 10/26/2026
For whom: Group leaders and managers · 17-minute read · 3 price ranges · 24 pages
Cover of the BOOPER white paper: Groupings: Harmonizing Market Prices Across a Pharmacy Network

Free Download

Get the white paper by email.
Thank you! We'll email you the white paper very soon.
Oops! Something went wrong while submitting the form.
By downloading, you agree to be contacted by Booper regarding this content. Your data will never be shared with third parties.

Give your pricing
the power of predictive analytics.

Plan ahead. Simulate. Decide. Execute.
Let's plan an exchange